Market Place
Sourcing Support
All News #Library
Others
Lonza`s Synaffix, Sidewinder Ink Multi-Target ADC Deal
08 Jan 2026 //
PHARMIWEB
Synaffix Named `Biotech Company of the Year` at LSX European Lifestars Awards
16 Nov 2022 //
PRNEWSWIRE
Synaffix Wins ‘Best ADC Platform Technology’ Award Again at World ADC
20 Sep 2022 //
PHARMIWEB
Synaffix allies with Emergence in $360M biobuck ADC pact
07 Sep 2022 //
FIERCEBIOTECH
Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal
06 Sep 2022 //
PRNEWSWIRE
Kyowa Kirin Expands License Agreement with Synaffix; Takes Excl. Target Rights
30 Jun 2022 //
PRNEWSWIRE
J&J`s Janssen joins Mersana ADC collabs in $1B biobucks pact
04 Feb 2022 //
FIERCEBIOTECH
Synaffix Inks $586m Deal with MacroGenics to Enable Next Generation ADCs
03 Feb 2022 //
PRESS RELEASE
With $415M on the line, Genmab taps Synaffix for ADC technology
05 Jan 2022 //
FIERCEBIOTECH
Synaffix Announces Expansion of Mersana License Deal Total Exceeding $1 Billion
30 Nov 2021 //
PRNEWSWIRE
Synaffix Announces Deal with ProfoundBio Worth up to $246 Million
22 Jul 2021 //
BUSINESSWIRE
Innovent Biologics Signs License Agreement with Synaffix
01 Jul 2021 //
CONTRACTPHARMA
Synaffix Licenses its Award-Winning ADC Technology in Deal
29 Jun 2021 //
BUSINESSWIRE
Synaffix Announces Expansion of Collaboration with ADC Therapeutics
22 Jul 2020 //
BUSINESSWIRE
Synaffix Announces Expansion of Collaboration with ADC Therapeutics
22 Jul 2020 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.